Donnenfeld, Eric <br/><br/>
A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.  [electronic resource] 

 -  Current medical research and opinion  Nov 2004 
 - 1753-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-7995 
<br/><br/><label>Standard No.: </label>10.1185/030079904X5959  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anterior Chamber--drug effects<br/>Aza Compounds--toxicity<br/>Conjunctiva--drug effects<br/>Eye--drug effects<br/>Female<br/>Fluoroquinolones--toxicity<br/>Gatifloxacin<br/>Humans<br/>Hyperemia--chemically induced<br/>Irritants<br/>Male<br/>Middle Aged<br/>Moxifloxacin<br/>Ophthalmic Solutions--toxicity<br/>Pain--chemically induced<br/>Pupil--drug effects<br/>Quinolines--toxicity